United Kingdom — National Health Service & Illumina — Holy Grail

United Kingdom — National Health Service: The United Kingdom — National Health Service (NHS) in the United Kingdom conducted the NHS-Galleri trial with Illumina — Holy Grail, Inc., the results of which are the basis for the securities fraud allegations.

Illumina — Holy Grail: Illumina — Holy Grail is the defendant in multiple class action lawsuits alleging securities fraud due to misleading statements about its NHS-Galleri trial results, which caused a significant drop in its stock price. The company's stock fell over 50% after it announced the trial did not meet its primary endpoint.

United Kingdom — National Health Service: The United Kingdom — National Health Service is the organization with which Illumina — Holy Grail conducted the NHS-Galleri trial, which is at the center of the securities fraud allegations.

Illumina — Holy Grail: Illumina — Holy Grail is the defendant in a securities fraud class action lawsuit after its stock plummeted over 50% due to alleged misrepresentations about its NHS-Galleri cancer trial results. The company faces significant legal and financial repercussions.